168 related articles for article (PubMed ID: 36865686)
1. The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease.
Li M; Liu D; Jing F; Liu R; Yi Q
Front Pediatr; 2023; 11():1111788. PubMed ID: 36865686
[TBL] [Abstract][Full Text] [Related]
2. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.
Yang M; Weng H; Pei Q; Jing F; Yi Q
Mediators Inflamm; 2021; 2021():7029514. PubMed ID: 33505217
[TBL] [Abstract][Full Text] [Related]
4. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
5. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
6. Explorative case control study on the associations of serum vitamin D3, folic acid and vitamin B12 levels on Kawasaki disease and coronary artery lesions.
Chen Y; Liu X; Li B; Li J; Meng L; Ye C; Han L; Li H; Deng LL; Su Z; Zhang X
Front Nutr; 2024; 11():1402316. PubMed ID: 38919394
[TBL] [Abstract][Full Text] [Related]
7. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
8. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
[TBL] [Abstract][Full Text] [Related]
10. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
Xu YM; Chu YQ; Wang H
Front Pediatr; 2021; 9():704929. PubMed ID: 34660478
[No Abstract] [Full Text] [Related]
11. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
[TBL] [Abstract][Full Text] [Related]
14. Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease.
Wu R; Jiang W; Sun Y; Wu L; Di Y; Wang J; Zhong S; Wang W
J Clin Rheumatol; 2023 Apr; 29(3):126-131. PubMed ID: 36730421
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
Yi L; Zhang J; Zhong J; Zheng Y
J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
[TBL] [Abstract][Full Text] [Related]
16. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of VEGF in the Pathogenesis of Kawasaki Disease.
Chen CY; Huang SH; Chien KJ; Lai TJ; Chang WH; Hsieh KS; Weng KP
Children (Basel); 2022 Sep; 9(9):. PubMed ID: 36138652
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy.
Senzaki H; Kobayashi T; Nagasaka H; Nakano H; Kyo S; Yokote Y; Sasakid N
Pediatr Res; 2003 Jun; 53(6):983-8. PubMed ID: 12621103
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
20. Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease.
Ching LL; Nerurkar VR; Lim E; Shohet RV; Melish ME; Bratincsak A
Front Pediatr; 2020; 8():295. PubMed ID: 32670996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]